ClinicalTrials.gg
Drug

Etelcalcetide clinical trials

Also written AMG 416, Parsabiv™ and KAI-4169.

studies test it
19
open now
2
in phase 3
9
first study started
2010

How each study uses etelcalcetide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the etelcalcetide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
7 Feb 2017 · PARSABIV · NDA 208325 (FDA, Drugs@FDA)
European Union
11 Nov 2016 · Parsabiv · EMEA/H/C/003995 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Etelcalcetide
18

Brand

Parsabiv™
11

Development codes

AMG 416
15
KAI-4169
8

Studies by the year they started

19 studies that test it; most in 2013 (5)

Studies that test etelcalcetide, by start year
YearStudies
20102
20112
20121
20135
20142
20171
20183
20193

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
5
Phase 3
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 2

Amgen (12) · KAI Pharmaceuticals (5) · Thomas Nickolas, MD MS (1) · Prim. Priv. Doz. Dr. Daniel Cejka (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test etelcalcetide, phase 3 first.

Studies

Open first, then newest update. How each study uses etelcalcetide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 19

As the comparator · 1 — what is tested is compared with etelcalcetide

Codes

What other systems call etelcalcetide · ClinicalTrials.gg INT006350

  • MeSH (NLM) C583569etelcalcetide hydrochlorideConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 60ME133FJBETELCALCETIDEConfirmed FDA, Wikidata
  • RxNorm 1876119Confirmed FDA, Wikidata
  • Wikidata Q21098973etelcalcetideConfirmed FDA, Wikidata
  • NCI Thesaurus C129712EtelcalcetideConfirmed FDA, Wikidata
  • DrugBank DB12865One source Wikidata

Also registered as etelcalcetide hydrochloride (UNII 72PT5993DU · RxNorm 1876122).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.